{"entity":{"type":"insider","cik":"0001341212","url":"/insider/0001341212","json_url":"/insider/0001341212.json","name":"Coissac Patrice","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2010-10-28","last":"2012-11-02","span_basis":"filed_date"},"name_variants":[{"name":"Coissac Patrice","source":"filing","n_filings":7,"first_seen":"2010-10-28","last_seen":"2012-11-02"}],"transactions":[{"id":2093324,"accession":"0001231977-12-000076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231977-12-000076","line_url":"/filing/0001231977-12-000076","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres. ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84764.0,"shares_display":"84,764","price_per_share":91.15766599027889,"price_display":"91.16","price_state":"stated","total_value":7726888.4,"total_display":"7,726,888.40","total_whole":"7,726,888","shares_owned_after":13148.0,"shares_owned_after_display":"13,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-31","filed_date":"2012-11-02","scope":"insider","n_lines":3},{"id":3500326,"accession":"0001231977-12-000071","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001231977-12-000071","line_url":"/filing/0001231977-12-000071#line-5","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres. ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21551.0,"shares_display":"21,551","price_per_share":106.37,"price_display":"106.37","price_state":"stated","total_value":2292379.87,"total_display":"2,292,379.87","total_whole":"2,292,380","shares_owned_after":85882.0,"shares_owned_after_display":"85,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-28","filed_date":"2012-08-29","scope":"insider"},{"id":3500321,"accession":"0001231977-12-000071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231977-12-000071","line_url":"/filing/0001231977-12-000071#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres. ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41932.0,"shares_display":"41,932","price_per_share":107.05,"price_display":"107.05","price_state":"stated","total_value":4488820.6,"total_display":"4,488,820.60","total_whole":"4,488,821","shares_owned_after":85882.0,"shares_owned_after_display":"85,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-27","filed_date":"2012-08-29","scope":"insider"},{"id":3140263,"accession":"0001231977-12-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231977-12-000035","line_url":"/filing/0001231977-12-000035#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres. ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":85.03,"price_display":"85.03","price_state":"stated","total_value":7652700.0,"total_display":"7,652,700.00","total_whole":"7,652,700","shares_owned_after":85882.0,"shares_owned_after_display":"85,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-24","scope":"insider"},{"id":8826165,"accession":"0001231977-11-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231977-11-000082","line_url":"/filing/0001231977-11-000082#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP & Pres. ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres. ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72766.0,"shares_display":"72,766","price_per_share":66.87,"price_display":"66.87","price_state":"stated","total_value":4865862.42,"total_display":"4,865,862.42","total_whole":"4,865,862","shares_owned_after":77882.0,"shares_owned_after_display":"77,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-18","scope":"insider"},{"id":9045460,"accession":"0001231977-11-000044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231977-11-000044","line_url":"/filing/0001231977-11-000044#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP, Pres ALXN Pharma Int'l)","role_mark":"O","role_mark_label":"Officer (SVP, Pres ALXN Pharma Int'l)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Pres ALXN Pharma Int'l","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":97.47,"price_display":"97.47","price_state":"stated","total_value":4386150.0,"total_display":"4,386,150.00","total_whole":"4,386,150","shares_owned_after":38941.0,"shares_owned_after_display":"38,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-14","scope":"insider"},{"id":9093577,"accession":"0001231977-11-000035","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231977-11-000035","line_url":"/filing/0001231977-11-000035","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (SVP, Pres Alxn Pharm Int)","role_mark":"O","role_mark_label":"Officer (SVP, Pres Alxn Pharm Int)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Pres Alxn Pharm Int","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52100.0,"shares_display":"52,100","price_per_share":92.85508714011516,"price_display":"92.86","price_state":"stated","total_value":4837750.04,"total_display":"4,837,750.04","total_whole":"4,837,750","shares_owned_after":38941.0,"shares_owned_after_display":"38,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-22","scope":"insider","n_lines":2},{"id":7326267,"accession":"0001231977-10-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231977-10-000068","line_url":"/filing/0001231977-10-000068#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001341212","owner_name":"Coissac Patrice","owner_display_name":"Coissac Patrice","owner_url":"/insider/0001341212","role":"Officer (GM/President ALXN SAS Europe)","role_mark":"O","role_mark_label":"Officer (GM/President ALXN SAS Europe)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GM/President ALXN SAS Europe","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":67.18,"price_display":"67.18","price_state":"stated","total_value":262002.0,"total_display":"262,002.00","total_whole":"262,002","shares_owned_after":33941.0,"shares_owned_after_display":"33,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (SVP & Pres. ALXN Pharma Int'l)","n_filings":7,"first_seen":"2010-10-28","last_seen":"2012-11-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341212","retrieved_at":"2026-08-27T10:44:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}